• 

  Clinical Application of Prognostic Factors and Their Integration in a Risk and Time to Treatment Assessment Scale for Treatment-Naive B-CLL Patients // Клинично приложение на прогностичните фактори и интегрирането им в скала за оценка на риска и времето до лечение, при нелекувани пациенти с В-хронична лимфоцитна левкемия 

  Vanya Popova / Ваня Попова (Medical University of Varna, 2020)

  Chronic lymphocytic leukaemia is one of the most common leukaemias in adults characterised by an extremely variable clinical course and different outcomes. It is defined by many factors associated with complex pathogenetic ...
• 

  The Quality Management System as a Factor for the Competitiveness of the Bulgarian Pharmaceutical Manufacturers // Системата за управление на качеството като фактор за повишаване на конкурентноспособността на българските фармацевтични производители 

  Reneta Stefanova / Ренета Стефанова (Medical University of Varna, 2020)

  This thesis aims to study the capabilities of the pharmaceutical Quality Management System to increase the competitiveness and specific expectations of the Bulgarian pharmaceutical manufacturers on this topic and propose ...
• 

  Role of the Nurse in the Blood Donation Process // Роля на медицинската сестра в процеса на кръводаряване 

  Milena Todorova / Милена Тодорова (Medical University of Varna, 2020)

  The present study provides a unique opportunity to identify the socio-medical aspects of blood donation and find ways of developing and asserting the nurse's role in the blood donation process.
• 

  Pharmacological Study of The Behavioural Effects of Chaenomeles Maulei in Experimental Animals // Фармакологично проучване на поведенчески ефекти на Chaenomeles maulei при експериментални животни 

  Vesela Borisova / Весела Борисова (Medical University of Varna, 2020)

  According to a World Health Organization report, psychiatric disorders affect more than 264 million people worldwide and are a leading cause of disability for people of all ages. Depression is one of the most common ...
• 

  RIP3 Marker Expression for Necroptosis in Cases of Prostate Cancer // Експресия на маркер за некроптоза RIP3 в случаи на простатен карцином 

  Kalin Kalchev / Калин Калчев (Medical University of Varna, 2020)

  The aim of this study is to assess the expression of the necroptotic marker RIP3 in prostate cancer tumour tissue in relation to clinical and pathological parameters and to define it's prognostic and predictive value for ...

View more